Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Syneos Health Inc (SYNH)
Syneos Health Inc (SYNH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,457,843
  • Shares Outstanding, K 103,719
  • Annual Sales, $ 5,393 M
  • Annual Income, $ 266,500 K
  • 60-Month Beta 1.58
  • Price/Sales 0.83
  • Price/Cash Flow 6.40
  • Price/Book 1.28
Trade SYNH with:
  • Price/Earnings ttm 14.87
  • Earnings Per Share ttm 2.89
  • Most Recent Earnings $0.01 on 08/08/23
  • Latest Earnings Date 11/02/23
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility 2.13%
  • IV Percentile 0%
  • IV Rank N/A
  • IV High 0.00% on N/A
  • IV Low 0.00% on N/A
  • Put/Call Vol Ratio N/A
  • Today's Volume N/A
  • Volume Avg (30-Day) N/A
  • Put/Call OI Ratio N/A
  • Today's Open Interest N/A
  • Open Int (30-Day) N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/23
See More
  • Average Estimate 0.68
  • Number of Estimates 1
  • High Estimate 0.68
  • Low Estimate 0.68
  • Prior Year 1.13
  • Growth Rate Est. (year over year) -39.82%

Price Performance

See More
Period Period Low Period High Performance
1-Month
42.48 +1.18%
on 08/28/23
43.64 -1.51%
on 09/13/23
+0.49 (+1.15%)
since 08/25/23
3-Month
41.91 +2.55%
on 07/03/23
43.64 -1.51%
on 09/13/23
+1.10 (+2.63%)
since 06/27/23
52-Week
22.89 +87.73%
on 11/04/22
52.23 -17.71%
on 10/26/22
-3.52 (-7.57%)
since 09/27/22

Most Recent Stories

More News
Civitas Resources Set to Join S&P MidCap 400; Hayward Holdings to Join S&P SmallCap 600

/PRNewswire/ -- S&P SmallCap 600 constituent Civitas Resources Inc. (NYSE: CIVI) will replace Syneos Health Inc. (NASD: SYNH) in the S&P MidCap 400, and...

SPGI : 437.20 (-0.04%)
SYNH : 42.98 (+0.02%)
CIVI : 62.35 (-0.95%)
HAYW : 12.91 (-0.15%)
SYNEOS 72 HOUR DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Syneos To Contact Him Directly To Discuss Their Options

/PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Syneos Health, Inc. ("Syneos" or the...

SYNH : 42.98 (+0.02%)
Attention SYNH Shareholders: Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of Securities Fraud Class Action Lawsuit Filed against Syneos Health, Inc. (SYNH) and Encourages Investors to Contact the Firm

/PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been against...

SYNH : 42.98 (+0.02%)
SYNH Investors Have Opportunity to Lead Syneos Health, Inc. Securities Fraud Lawsuit

/PRNewswire/ -- Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action...

SYNH : 42.98 (+0.02%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Syneos Health, Inc. - SYNH

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Syneos Health, Inc. ("Syneos" or the "Company") (NASDAQ: SYNH). Such investors...

SYNH : 42.98 (+0.02%)
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Syneos Health, Inc.(SYNH) Investors of a Class Action Lawsuit and Upcoming Deadline

/PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Syneos Health, Inc. ("Syneos" or the "Company") (NASDAQ: SYNH) of a class action securities lawsuit....

SYNH : 42.98 (+0.02%)
SYNH Investors Have Opportunity to Lead Syneos Health, Inc. Securities Fraud Lawsuit

/PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action...

SYNH : 42.98 (+0.02%)
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Syneos Health, Inc. Investors to Secure Counsel Before Important September 25 Deadline in Securities Class Action - SYNH

/PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Syneos Health, Inc. (NASDAQ: SYNH) between...

SYNH : 42.98 (+0.02%)
SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Syneos Investors of a Lead Plaintiff Deadline of September 25, 2023

/PRNewswire/ -- Attention Syneos Health, Inc. ("Syneos") (NASDAQ: SYNH) shareholders: The Law Offices of Vincent Wong announce that a class action lawsuit has...

SYNH : 42.98 (+0.02%)
SYNH Investors Have Opportunity to Lead Syneos Health, Inc. Securities Fraud Lawsuit

/PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action...

SYNH : 42.98 (+0.02%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Syneos Health, Inc. is a key global biopharmaceutical solutions company offering a broad range of clinical and commercial facilities. The company majorly serves customers in the biopharmaceutical, biotechnology and medical device industries. Through its Contract Research Organization (CRO) and Contract...

See More

Key Turning Points

3rd Resistance Point 43.01
2nd Resistance Point 43.00
1st Resistance Point 42.99
Last Price 42.98
1st Support Level 42.97
2nd Support Level 42.96
3rd Support Level 42.95

See More

52-Week High 52.23
Last Price 42.98
Fibonacci 61.8% 41.02
Fibonacci 50% 37.56
Fibonacci 38.2% 34.10
52-Week Low 22.89

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar